News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here.

Recommended Reading

FDA approves rituximab for treating pemphigus vulgaris
MDedge Dermatology
Extramammary Paget Disease: Making the Correct Diagnosis
MDedge Dermatology
Surgical Procedures for Hidradenitis Suppurativa
MDedge Dermatology
Oral drug seen preventing angioedema attacks
MDedge Dermatology
Study offers snapshot of esophageal strictures in EB patients
MDedge Dermatology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Dermatology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Dermatology
RFPs Available for the Study of Three Rare Diseases
MDedge Dermatology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Dermatology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Dermatology